Paxlovid received FDA approval after showing in a Phase II/III clinical trial that it reduces severe disease, hospitalization and death by 89% when patients are treated early.
Source: Jerusalem Post
Full Article: Pfizer COVID-19 pills to arrive in Israel on Wednesday - Bennett
